Emerging research has consistently shown that Galectin-3 mediates fibrosis, exemplified by inhibiting Galectin-3 that reduces the inflammatory activation of TLR4 and downstream NF-κB to prevent myocardial fibrosis [38]. The gene discussed is NFKB1; the disease is Myocardial fibrosis.